Baby Food Safety Act of 2026
- Sponsor
- Rep. Krishnamoorthi, Raja [D-IL-8]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Apr 22, 2026
Bottom line
The Baby Food Safety Act of 2026 establishes new federal standards and mandates for testing and limiting toxic elements in infant and toddler foods, significantly increasing regulatory oversight to protect public health.
What it actually does
This bill amends the Federal Food, Drug, and Cosmetic Act to mandate the Food and Drug Administration (FDA) establish limits for toxic elements like lead, cadmium, mercury, and arsenic in infant and toddler food, as well as in fruit/vegetable purees and juices. It requires manufacturers of these foods to implement control programs, conduct regular sampling and testing of their final products, and maintain detailed records. Furthermore, the bill enhances the FDA's authority regarding record access, importer requirements, and mandatory recalls for adulterated food, aiming to bolster food safety for young children.
Proponents argue
Proponents argue that this bill is a critical step to protect the health and development of infants and toddlers by significantly reducing their exposure to harmful toxic elements found in certain foods. They contend that mandatory limits, robust testing requirements, and enhanced FDA enforcement are essential to ensure the safety of the food supply for the most vulnerable population, addressing a long-standing public health concern and building consumer trust.
Opponents contend
Opponents might raise concerns about the potential for increased regulatory burden and compliance costs on food manufacturers, particularly smaller businesses, which could lead to higher prices for consumers or reduced product availability. They may also argue that setting overly stringent limits for naturally occurring elements could be challenging to meet without impacting the nutritional quality or accessibility of certain foods, and that existing regulations, while perhaps needing enhancement, are sufficient.
The bill is relatively concise, allowing for a thorough reading and understanding within a reasonable timeframe, making it accessible for informed evaluation.
Section 2, amending Section 201 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321)
Definition of Infant or Toddler Food
This provision formally defines 'infant or toddler food' within the Federal Food, Drug, and Cosmetic Act as food that is represented for infants or children up to 24 months of age. It explicitly excludes infant formula from this definition. This new definition is crucial as it establishes the scope for all subsequent regulations and requirements introduced by the bill concerning these specific food products.
Supporters argue
Proponents argue that a clear, statutory definition of 'infant or toddler food' is essential for effective regulation, ensuring that all relevant products are consistently covered by the new safety standards without ambiguity. This clarity facilitates compliance for manufacturers and provides assurance for consumers.
Critics contend
No specific opposition is typically raised against definitional provisions that clarify regulatory scope, provided the definition itself is not overly broad or narrow in a way that creates unintended consequences.
Tradeoffs
The primary tension is ensuring the definition is precise enough to cover all intended products without inadvertently including or excluding items that should or should not be subject to these specific regulations.
Section 3(a), adding Section 425(a) to the Federal Food, Drug, and Cosmetic Act
Mandatory Limits on Toxic Elements in Infant and Toddler Food
This provision mandates the Secretary of Health and Human Services (acting through the FDA) to establish administrative orders setting limits for lead, cadmium, mercury, and arsenic in infant/toddler food and in foods predominantly composed of fruit or vegetable puree or juice. The FDA must also consider additional limits for other contaminants. These limits must be based on health data, consider unavoidable presence, and follow a public comment process, with specific deadlines for proposed and final orders.
Section 3(a), adding Section 425(b) to the Federal Food, Drug, and Cosmetic Act
Mandatory Sampling and Testing for Contaminants
This provision requires owners and operators of facilities manufacturing or processing infant/toddler food or fruit/vegetable purees/juices to implement a control program for toxic elements, collect representative samples, and conduct testing of final products. They must develop a written sampling and testing plan, test for lead, cadmium, mercury, and arsenic (and other specified contaminants), and maintain records for at least two years. Testing must be performed by accredited laboratories. The FDA is also mandated to develop its own sampling and testing program.
Section 3(c), amending Section 402 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 342)
Adulteration of Food for Non-Compliance
This amendment expands the definition of 'adulterated food' to include infant and toddler food, fruit/vegetable purees/juices, or other specified foods that contain toxic elements or contaminants in excess of established limits. It also deems food adulterated if the manufacturing facility fails to comply with the new sampling, testing, and recordkeeping requirements of Section 425(b) or (c). This provides a strong enforcement mechanism for the new safety standards.
Section 4(a)
FDA Implementation Plan for Food Traceability
This section requires the Secretary of Health and Human Services, through the FDA, to finalize an implementation plan by January 20, 2027, for the FDA's rule on 'Requirements for Additional Traceability Records for Certain Foods.' The plan must detail resource needs, strategies for facilitating compliance, and communication/education plans for regulated entities and staff. This aims to ensure effective rollout and adherence to existing traceability regulations.
Section 5, amending Section 704(a)(4) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 374(a)(4))
Remote Inspection Authority and Records in Lieu of In-Person Inspections
This provision expands the FDA's authority to request and obtain records or other information remotely from food establishments. It allows such records to be provided in advance of, at the time of, or in lieu of an in-person, on-site inspection, especially if an in-person inspection would be unsafe. This applies to records related to manufacturing, processing, sampling, testing, packing, transporting, distributing, receiving, holding, or importing food, or the distribution/use of veterinary feed directive drugs.
Section 6, amending Section 423(a) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 350l(a))
Expanded Mandatory Recall Authority
This amendment expands the FDA's mandatory recall authority to include situations where an article of food is adulterated under Section 402(a)(1) (containing a poisonous or deleterious substance that may render it injurious to health) or Section 402(j) (the new adulteration criteria established by this bill for infant/toddler food contaminants or non-compliance). Previously, mandatory recall authority was more limited, primarily to certain foods where there is a reasonable probability that the food is adulterated or misbranded and that the use of or exposure to the food will cause serious adverse health consequences or death to humans or animals. This broadens the scope to include the new contaminant limits.
The requirements for sampling and testing under the new Section 425(b) of the Federal Food, Drug, and Cosmetic Act will not apply until two years after the date of enactment of this subsection.
Section 3(d)
Why it matters:This is standard legislative practice to provide regulated entities with a transition period to develop and implement the necessary control programs, sampling plans, and testing protocols. It acknowledges the significant operational changes required by the bill.
Case for: Proponents would argue that this delayed applicability is a pragmatic approach, giving manufacturers sufficient time to adapt their processes, invest in new equipment or laboratory services, and train personnel to comply with the new, complex requirements without immediate disruption to the food supply.
Case against: Critics might argue that a two-year delay postpones critical safety measures for infants and toddlers, leaving them exposed to potentially harmful levels of contaminants for an extended period. They might advocate for a shorter implementation timeline given the urgency of the public health issue.
Estimated impact: This delay impacts the immediate realization of the bill's safety benefits, pushing back the full enforcement of manufacturer testing requirements by two years, while allowing industry time to prepare.
This amendment adds 'monitoring and verifying the accuracy of records described in section 425(b)' to the list of responsibilities for importers under the Foreign Supplier Verification Programs (FSVP). This means importers must not only ensure their foreign suppliers meet U.S. safety standards but specifically verify the accuracy of the new sampling and testing records required by this bill.
Section 3(b), amending Section 805(c)(4) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 384a(c)(4))
Why it matters:This is standard legislative drafting to integrate new requirements into existing regulatory frameworks. It ensures that the new domestic safety standards are mirrored for imported products through the established FSVP mechanism.
Case for: Proponents argue that this amendment is crucial for ensuring that imported infant and toddler foods meet the same rigorous safety standards as domestically produced foods. It closes a potential loophole and provides an additional layer of protection for consumers.
Case against: Industry might argue that adding specific record verification requirements to FSVP could increase the burden on importers, particularly for those dealing with a wide array of foreign suppliers, requiring more extensive due diligence and potentially increasing import costs.
Estimated impact: This provision significantly strengthens the oversight of imported infant and toddler foods, ensuring foreign suppliers are held to the same new testing and recordkeeping standards as domestic producers.